We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study.
- Authors
Shukuya, Takehito; Yasui, Hirofumi; Boku, Narikazu; Onozawa, Yusuke; Fukutomi, Akira; Yamazaki, Kentaro; Taku, Keisei; Kojima, Takashi; Machida, Nozomu
- Abstract
Peritoneal metastasis is one of the major sites of disease progression of pancreatic cancer. There have been few trials in the second-line setting after gemcitabine failure because patients can hardly be candidates for chemotherapy after failure in the first-line chemotherapy, especially those with malignant ascites. The safety and efficacy of weekly paclitaxel therapy was evaluated for pancreatic cancer patients with malignant ascites in this retrospective study.
- Publication
Japanese journal of clinical oncology, 2010, Vol 40, Issue 12, p1135
- ISSN
1465-3621
- Publication type
Journal Article
- DOI
10.1093/jjco/hyq117